Comparison of the Efficacy of Two Different Modified Release Methylphenidate Preparations for Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a Natural Setting: Comparison of the Efficacy of Medikinet <sup>®</sup> Retard and Concerta <sup>®</sup> —a Randomized, Controlled, Double-Blind Multicenter Clinical Crossover Trial - Concepedia

Concepedia

Publication | Closed Access

Comparison of the Efficacy of Two Different Modified Release Methylphenidate Preparations for Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a Natural Setting: Comparison of the Efficacy of Medikinet <sup>®</sup> Retard and Concerta <sup>®</sup> —a Randomized, Controlled, Double-Blind Multicenter Clinical Crossover Trial

19

Citations

21

References

2011

Year

Manfred Döpfner, Claudia Ose, Roland Fischer, Richard Ammer, André Scherag

Journal of Child and Adolescent Psychopharmacology

Abstract

Children and adolescents may be treated with a lower daily dose of Medikinet retard (which has a similar IR component as Concerta) without resulting in a clinically relevant worse effect during school time.

References

	Year	Citations
General hospital psychiatry: the Italian experience. PubMed Psychiatric EvaluationMental HealthGeneral Hospital PsychiatrySocial SciencesHospital Medicine	2003	1.3K
Attention-Deficit Hyperactivity Disorder Russell A. Barkley Scientific American AdhdNeuropsychologyPsychiatryAttention-deficit Hyperactivity DisorderMedicine	1998	681
Randomized, Controlled Trial of OROS Methylphenidate Once a Day in Children With Attention-Deficit/Hyperactivity Disorder Mark L. Wolraich, Laurence L. Greenhill, William E. Pelham, PEDIATRICS	2001	508
Once-a-Day Concerta Methylphenidate Versus Three-Times-Daily Methylphenidate in Laboratory and Natural Settings William E. Pelham, Elizabeth M. Gnagy, Lisa Burrows-MacLean, PEDIATRICS AdhdNatural EnvironmentPsychoactive DrugPsychiatryMedicine	2001	376
Impairment and Deportment Responses to Different Methylphenidate Doses in Children With ADHD: The MTA Titration Trial LAURENCE L. GREENHILL, James M. Swanson, BENEDETTO VITIELLO, Journal of the American Academy of Child & Adolescent Psychiatry Mta Titration TrialAdhdDeportment ResponsesPsychiatryAddiction	2001	290
A Comparison of Once-Daily Extended-Release Methylphenidate Formulations in Children With Attention-Deficit/Hyperactivity Disorder in the Laboratory School (The Comacs Study) James M. Swanson, Sharon B. Wigal, Tim Wigal, PEDIATRICS	2004	238
A Dose-Response Study of OROS Methylphenidate in Children With Attention-Deficit/Hyperactivity Disorder Mark A. Stein, Christopher S. Sarampote, Irwin D. Waldman, PEDIATRICS	2003	233
Comparing the efficacy of medications for ADHD using meta-analysis. Stephen V. Faraone, Joseph Biederman, Thomas Spencer, PubMed	2006	232
How often do children meet ICD-10/DSM-IV criteria of attention deficit-/hyperactivity disorder and hyperkinetic disorder? Parent-based prevalence rates in a national sample – results of the BELLA study European Child & Adolescent Psychiatry Child PsychologyAdhdBella StudyParent-based Prevalence RatesPsychiatry	2008	197
Multisite Controlled Study of OROS Methylphenidate in the Treatment of Adolescents With Attention-Deficit/Hyperactivity Disorder Timothy E. Wilens, Keith McBurnett, Oscar G. Bukstein, Archives of Pediatrics and Adolescent Medicine	2006	160

Page 1